NEOSTIGMINE METHYLSULFATE
NDC 14445-414, NEOSTIGMINE METHYLSULFATE, injection, from Indoco Remedies Limited.
- Product NDC
- 14445-414
- Status
- Listed
- Labeler
- Indoco Remedies Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210652
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14445-414 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14445-414-01 | 14445041401 | 10 CARTON in 1 PACKAGE (14445-414-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (14445-414-10) / 10 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6657402f-1db2-411e-bf66-fca3902756c4
Use it
Look up 14445-414 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14445-414 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14445-414. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.